Uterine NK Cells Regulate Endometrial Bleeding in Women and Are Suppressed by the Progesterone Receptor Modulator Asoprisnil

被引:72
|
作者
Wilkens, Julia [1 ]
Male, Victoria [2 ]
Ghazal, Peter [3 ]
Forster, Thorsten [3 ]
Gibson, Douglas A. [1 ]
Williams, Alistair R. W. [1 ]
Brito-Mutunayagam, Savita L. [1 ]
Craigon, Marie [3 ]
Lourenco, Paula [1 ]
Cameron, Iain T. [4 ]
Chwalisz, Kristof [5 ]
Moffett, Ashley [2 ]
Critchley, Hilary O. D. [1 ]
机构
[1] Univ Edinburgh, MRC, Ctr Reprod Hlth, Edinburgh EH16 4TJ, Midlothian, Scotland
[2] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England
[3] Univ Edinburgh, Div Pathway Med, Edinburgh EH16 4SB, Midlothian, Scotland
[4] Univ Southampton, Fac Med, Southampton SO17 1BJ, Hants, England
[5] Abbott Labs, Abbott Pk, IL 60064 USA
来源
JOURNAL OF IMMUNOLOGY | 2013年 / 191卷 / 05期
基金
英国惠康基金; 英国医学研究理事会;
关键词
NATURAL-KILLER-CELLS; T-CELLS; EXPRESSION; IL-15; PROLIFERATION; TROPHOBLAST; INTERLEUKIN-15; LEIOMYOMATA; MORPHOLOGY; LEUKOCYTES;
D O I
10.4049/jimmunol.1300958
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Uterine NK cells (uNK) play a role in the regulation of placentation, but their functions in nonpregnant endometrium are not understood. We have previously reported suppression of endometrial bleeding and alteration of spiral artery morphology in women exposed to asoprisnil, a progesterone receptor modulator. We now compare global endometrial gene expression in asoprisnil-treated versus control women, and we demonstrate a statistically significant reduction of genes in the IL-15 pathway, known to play a key role in uNK development and function. Suppression of IL-15 by asoprisnil was also observed at mRNA level (p < 0.05), and immunostaining for NK cell marker CD56 revealed a striking reduction of uNK in asoprisnil-treated endometrium (p < 0.001). IL-15 levels in normal endometrium are progesterone-responsive. Progesterone receptor (PR) positive stromal cells transcribe both IL-15 and IL-15RA. Thus, the response of stromal cells to progesterone will be to increase IL-15 trans-presentation to uNK, supporting their expansion and differentiation. In asoprisnil-treated endometrium, there is a marked downregulation of stromal PR expression and virtual absence of uNK. These novel findings indicate that the IL-15 pathway provides a missing link in the complex interplay among endometrial stromal cells, uNK, and spiral arteries affecting physiologic and pathologic endometrial bleeding.
引用
收藏
页码:2226 / 2235
页数:10
相关论文
共 50 条
  • [1] Asoprisnil, a novel selective progesterone receptor modulator (SPRM), controls abnormal uterine bleeding in subjects with leiomyomata
    Chwalisz, K
    Larsen, L
    Mattia-Goldberg, C
    McCrary, K
    Edmonds, A
    Human Reproduction, 2005, : 556 - 556
  • [2] A randomized, controlled trial of asoprisnil, a novel selective progesterone receptor modulator, in women with uterine leiomyomata
    Chwalisz, Kristof
    Larsen, Lois
    Mattia-Goldberg, Cynthia
    Edmonds, Anthony
    Elger, Walter
    Winkel, Craig A.
    FERTILITY AND STERILITY, 2007, 87 (06) : 1399 - 1412
  • [3] Asoprisnil -: Endometriosis therapy treatment of uterine fibroids selective progesterone receptor modulator
    Cole, P
    Castañer, J
    Fernández-Forner, D
    DRUGS OF THE FUTURE, 2005, 30 (10) : 985 - 991
  • [4] Selective progesterone receptor modulator asoprisnil induces endoplasmic reticulum stress in cultured human uterine leiomyoma cells
    Xu, Qin
    Ohara, Noriyuki
    Liu, Jin
    Nakabayashi, Koji
    DeManno, Deborah
    Chwalisz, Kristof
    Yoshida, Shigeki
    Maruo, Takeshi
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2007, 293 (04): : E1002 - E1011
  • [5] Effects of the novel selective progesterone receptor modulator (SPRM) asoprisnil on bleeding patterns in subjects with leiomyomata.
    Chwalisz, K
    Larsen, L
    McCrary, K
    Edmonds, A
    JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2004, 11 (02) : 320A - 321A
  • [6] A structural and in vitro characterization of asoprisnil:: A selective progesterone receptor modulator
    Madauss, Kevin P.
    Grygielko, Eugene T.
    Deng, Su-Jun
    Sulpizio, Anthony C.
    Stanley, Thomas B.
    Wu, Charlene
    Short, Steve A.
    Thompson, Scott K.
    Stewart, Eugene L.
    Laping, Nicholas J.
    Williams, Shawn P.
    Bray, Jeffrey D.
    MOLECULAR ENDOCRINOLOGY, 2007, 21 (05) : 1066 - 1081
  • [7] Study of uterine prostaglandins under the selective progesterone receptor modulator (SPRM) asoprisnil, progestins, and antiprogestins in guinea pigs
    Elger, W
    Nandy, A
    Rasch, A
    Reddersen, G
    Triller, A
    Chwalisz, K
    Human Reproduction, 2005, : 776 - 776
  • [8] Therapeutic potential for the selective progesterone receptor modulator asoprisnil in the treatment of leiomyomata
    Chwalisz, K
    DeManno, D
    Garg, R
    Larsen, L
    Mattia-Goldberg, C
    Stickler, T
    SEMINARS IN REPRODUCTIVE MEDICINE, 2004, 22 (02) : 113 - 119
  • [9] The effects of the selective progesterone receptor modulator asoprisnil on the morphology of uterine tissues after 3 months treatment in patients with symptomatic uterine leiomyomata
    Williams, A. R. W.
    Critchley, H. O. D.
    Osei, J.
    Ingamells, S.
    Cameron, I. T.
    Han, C.
    Chwalisz, K.
    HUMAN REPRODUCTION, 2007, 22 (06) : 1696 - 1704
  • [10] Treatment of endometriosis with the novel selective progesterone receptor modulator (SPRM) asoprisnil.
    Chwalisz, K
    Mattia-Goldberg, C
    Lee, M
    Elger, W
    Edmonds, A
    FERTILITY AND STERILITY, 2004, 82 : S83 - S84